I want to ask you about your research that's calling into question what we've understood for years about type 1 diabetes, which is no longer called childhood diabetes.
MF:
Are type 1 and type 2 diabetes different diseases?
ES:
What makes type 1 diabetes so difficult to diagnose?
MF:
Can you talk about the different treatments?
MF:
ES:
Type 1 diabetes was once thought of as a skinny person's disease, but that's no longer the case.
MF:
There has been a lot of buzz about the GLP-1 drugs Ozempic and Mounjaro for people with diabetes and those who are overweight to lose weight and reverse diabetes. Where does this drug fit into this population?
ES:do not have
MF:
ES:
Are there concerns about misdiagnosis or inappropriate treatment? Could a patient think they have type 2 but actually have type 1?
MF:
Where will this research go next?
ES:
This can be confusing for people with type 1 diabetes.You hear stories of people losing weight on these medications, and then you go to the doctor and they say, “Yeah, but that's not right for you.”
ES:
MF:
Another big topic we hear about in diabetes is insulin and its price. Can you talk about your research on this subject?
MF:
Medicare currently covers less expensive insulin for people over 65, but cost is an issue for many. Can you expand on that?
MF:
Annals of Internal Medicine
ES: